KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, has discovered how cancer cells can ...

Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy for cancers that form solid tumors, including ...

Better mRNA release inside cells boosts vaccine and gene editing performance, enabled by redesigned lipid molecules that grip ...

A lipid hidden within cells called phosphatidylserine reveals how the body initiates the removal of threats and cellular debris.

To test whether AT2‑derived lipids are required for metastasis, the researchers selectively deleted Fasn in AT2 cells.

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general ...

Researchers at the University of Queensland have reported that the balance of dietary fats can alter the composition and ...

Increasing the efficiency of LNPs as therapeutic vehicles offers promise for better mRNA-based and gene editing treatment success.

Clear cell renal cell carcinoma (ccRCC) is a common type of cancer in the urinary system. Currently, the first-line treatments for advanced or metastatic ccRCC are tyrosine kinase inhibitors (TKIs); ...

Scientists have built functional cancer-fighting immune cells directly inside living animals, skipping the expensive and time-consuming process of extracting a patient’s cells and engineering them in ...